Meghann Teague
About Meghann Teague
Meghann Teague serves as the Head of Intellectual Property at Adaptimmune, bringing extensive experience in patent law and scientific research. She has held positions at Cooley LLP and Northwestern University, and she holds degrees in Microbiology and Immunology, as well as a Juris Doctor.
Current Role at Adaptimmune
Meghann Teague serves as the Head of Intellectual Property at Adaptimmune, a position she has held since 2023. In this role, she is responsible for overseeing the company's intellectual property strategy and ensuring the protection of its innovations in the field of immunotherapy. Her expertise in patent law and scientific research supports Adaptimmune's mission to develop advanced therapies for cancer treatment.
Previous Experience at Cooley LLP
Meghann Teague worked at Cooley LLP for a total of ten years, from 2012 to 2022. During her tenure, she held two positions: first as a Patent Agent and later as a Patent Attorney. In these roles, she provided legal counsel on patent matters, focusing on the intersection of law and biotechnology. Her experience at Cooley LLP equipped her with substantial knowledge in intellectual property law, particularly in the life sciences sector.
Academic Background
Meghann Teague has a robust academic background in the life sciences and law. She earned her Bachelor of Science in Microbiology from the University of Illinois Urbana-Champaign, completing her studies from 1997 to 2001. She then pursued a Doctor of Philosophy in Immunology and Microbial Pathogenesis at Northwestern University - The Feinberg School of Medicine, where she studied from 2001 to 2006. Additionally, she obtained her Juris Doctor from Georgetown University Law Center, studying from 2013 to 2017.
Postdoctoral Experience
Meghann Teague has held postdoctoral fellowships at prestigious institutions. She worked at Northwestern University - Feinberg School of Medicine for one year from 2008 to 2009, and at the University of Sydney for two years from 2006 to 2008. These positions allowed her to deepen her research expertise in immunology and microbial pathogenesis, contributing to her comprehensive understanding of the scientific principles underlying her current work in intellectual property.